Georgia Composite Medical Board advertising rules — a marketing guide for physicians and practices
A practical field guide for marketing leads and practice operators serving Georgia-licensed physicians. Written against the Medical Practice Act of Georgia (O.C.G.A. § 43-34), the Georgia Composite Medical Board rules at Chapter 360-3, and the Georgia Fair Business Practices Act (O.C.G.A. § 10-1-390 et seq.) as it applies to healthcare advertising.
- The Medical Practice Act of Georgia at O.C.G.A. § 43-34-8 makes false, fraudulent or misleading advertising a ground for licence discipline by the Georgia Composite Medical Board — up to and including revocation.
- The Board's professional-conduct rules at Chapter 360-3 of the Rules of the Georgia Composite Medical Board operationalise the statute, cover physicians and physician assistants and their advertising, and layer with the Georgia Fair Business Practices Act (O.C.G.A. § 10-1-390) enforced by the state Attorney General.
- Testimonials, before-and-after and outcome claims are the highest-risk surfaces. Consideration must be disclosed. Atypical outcomes require an equal-prominence "results not typical" line. Identified patients require prior HIPAA authorisation.
- Georgia's telehealth licensure regime under O.C.G.A. § 43-34-31 and Board Rule 360-3-.09 requires that a physician treating a Georgia patient by telehealth hold a Georgia licence — advertising must be truthful about who is Georgia-licensed and available.
- Georgia advertising rules layer on federal HIPAA, FTC 16 CFR 255, TCPA and ADA. Nothing in Georgia rules relaxes any federal requirement.
-
Primary Care · North Dallas, TXCase study →
-
MedSpa · North Dallas, TX
-
Skin Care · Beverly Hills, CA
-
Dental · Christiansburg, VACase study →
-
Pediatrics · Blacksburg, VACase study →
-
Pediatric Dentistry · Blacksburg, VACase study →
-
Dental · Roanoke, VACase study →
-
Functional Medicine · Telehealth · USACase study →
“They were able to get all my ideas and work with me over a period of three to four months and create this amazing website. It's super customized, very modern, and it incorporates all the elements that I had wanted — the patient portal, nice pictures, a very interactive website, patient reviews. I would highly recommend their company to anyone who wants to make an excellent website.”
On this page
- Who enforces physician advertising in Georgia
- What Georgia calls "advertising" — and the deceptive-practice standard
- Testimonials, before-and-after and outcome claims
- Credentials, specialties and titles
- Discounts, comparative claims and superlatives
- Telehealth advertising and the Georgia licensure overlay
- Digital advertising — SEO, ads, social, review platforms
- Enforcement patterns and disciplinary risk
- Federal overlay — HIPAA, FTC, TCPA, ADA
- FAQ
Who enforces physician advertising in Georgia
Two Georgia bodies matter for a physician marketing programme. The Georgia Composite Medical Board (GCMB) is the professional-review body constituted under O.C.G.A. § 43-34-2 with authority to discipline licensees for advertising violations. The Georgia Office of the Attorney General enforces the Georgia Fair Business Practices Act at O.C.G.A. § 10-1-390 et seq., which reaches deceptive healthcare advertising through a consumer-protection lens independent of Board discipline. Both can act on the same underlying conduct.
Every physician holding a Georgia MD or DO licence, plus every physician assistant licensed under O.C.G.A. § 43-34-102 and every advanced-practice nurse who publishes advertising under a supervising physician's roster, is under Chapter 360-3 for advertising purposes. A licensee is responsible for advertising placed by employees, contractors and agents on the licensee's behalf. Outsourcing marketing to an agency does not transfer professional responsibility for the content — every US healthcare engagement at Ichelon Consulting US runs advertising through a named-licensee sign-off step before publication.
Who is covered
The Board's jurisdiction reaches every MD, DO, physician assistant, and cosmetic-laser services provider licensed under O.C.G.A. Chapter 43-34. Multi-state groups with any Georgia-licensed physician on the roster are exposed to Georgia's rules for any advertising that reaches Georgia patients, regardless of the group's principal place of business.
Board-approved framing is unavailable
The Georgia Composite Medical Board does not preapprove advertising and does not endorse specific campaigns. Any pitch, deck or website that claims "GCMB-approved" advertising is itself a deceptive statement under O.C.G.A. § 43-34-8. The defensible phrasing is that a campaign has been "reviewed against Georgia medical-board advertising rules" — truthful, non-implicative, and verifiable.
What Georgia calls "advertising" — and the deceptive-practice standard
Georgia uses a functional definition of advertising for Board purposes. Any statement in any medium published by or on behalf of a licensee that promotes, invites or induces patronage of the licensee's professional services qualifies. Paid media in every channel is covered, and so is unpaid content published by or on behalf of the licensee: practice websites, Google Business Profile listings, professional social-media accounts, review-platform responses, patient-education videos, downloadable guides, webinars, and podcast appearances in a promotional context.
The deceptive-practice standard at O.C.G.A. § 43-34-8(a)(7) and Rule 360-3 reaches three related failure modes.
- Material misrepresentation. An affirmative statement that is factually incorrect on a point a reasonable patient would find material to the decision to seek care.
- Material omission. Leaving out a fact a reasonable patient would need to interpret the advertisement correctly.
- Unjustified expectation of results. Language, imagery, or juxtaposition that leaves a reasonable patient with an inflated expectation of outcome, even where every individual statement is technically accurate.
The Georgia Composite Medical Board reads the "overall impression" prong strictly. A page that pairs an emotionally-loaded testimonial with an idealised body-transformation photograph and a "book now" call-to-action creates an unjustified therapeutic expectation. The safer construction is non-idealised imagery, testimonial captions that state the technique and the interval, and outcome descriptions expressed in ranges with typicality disclosures.
Testimonials, before-and-after and outcome claims
Testimonial and outcome-claim risk is the single highest-frequency source of Georgia Composite Medical Board complaints against physicians on advertising grounds. Four operating rules apply.
- Identification. The testimonial must be identified as such.
- Currency. Testimonials must be current about a service still offered, a physician still on the roster, and a technique still in clinical use.
- Consideration disclosure. Any value given for the testimonial — discount, gift, service credit, cash, published visibility — must be disclosed clearly on the same face as the testimonial. Georgia expectations align with the FTC endorsement guides at 16 CFR Part 255.
- Typicality. If the outcome is not typical for a reasonable patient with similar presentation, a "results not typical" line at equal prominence is required.
Before-and-after imagery
Before-and-after content is testimonial-grade in Georgia. Every set requires an on-image or immediately adjacent caption with technique, interval, session count, and — where relevant to outcome interpretation — patient age at both photographs. Retouching, filter manipulation, or lighting normalisation that alters the depicted outcome is a material misrepresentation. Original unretouched files, date-stamped consent forms and technique logs need to be retained for the six-year HIPAA period.
HIPAA overlay on testimonials
Any Georgia testimonial that identifies a patient is a use of PHI under 45 CFR 164.508 and requires prior written authorisation. State advertising rules do not relax federal HIPAA rules — every requirement stacks.
Credentials, specialties and titles
Georgia takes credentialling and titling claims strictly under Rule 360-3. Three tripwires recur.
- Board certification. "Board-certified" is safe when the certifying body is a member of the American Board of Medical Specialties (ABMS) or the American Osteopathic Association Bureau of Osteopathic Specialists (AOA-BOS). Certifications from private organisations that award them for a fee, without a defensible examination and training standard, must be identified by the full name of the certifying body and cannot be shortened.
- Fellowship claims. A "fellowship-trained" claim must reflect completion of a formal accredited fellowship in the named specialty.
- "Specialising in" and "expert in". Permissible where the physician has substantial training and practice concentration in the area, and only when they do not imply a certification the physician does not hold.
Physician-performed versus physician-supervised
Georgia distinguishes services performed by a physician from services performed by a non-physician under physician supervision. Cosmetic injectables, laser treatments, and aesthetic procedures administered by a registered nurse or physician assistant under supervision cannot be advertised as "administered by our physicians". Georgia has a specific rule regime for cosmetic-laser services under O.C.G.A. § 43-34-240 that requires the treating professional's licence category to be identified in advertising.
Discounts, comparative claims and superlatives
Georgia permits discount and promotional pricing when the terms are clear and the offer is genuine. Four fail-modes recur in Board proceedings on offer advertising.
- Phantom baseline. A "50% off" claim requires a genuine, prevailing reference price. Fabricated baselines are deceptive under both O.C.G.A. § 43-34-8 and the Fair Business Practices Act.
- Expiration and eligibility. Every offer must state its expiration date and material eligibility conditions on the same face.
- Bait-and-switch. Advertising a service at a price and routinely upselling patients is prohibited unless the upsell is clinically indicated and separately consented.
- Inducement to unnecessary care. Offers that reward patients for undergoing services not medically indicated are inducement under Rule 360-3 and can implicate the federal Anti-Kickback Statute where federal healthcare programme payment is involved.
Comparative claims
Comparative claims that name a specific competing practice or physician are high-risk in Georgia. The safer construction describes the practice's own capabilities and outcomes on the practice's own terms, without any named-competitor reference. Categorical comparison to published federal or state statistics with a citation is defensible where the underlying data is public and verifiable.
Superlatives
Superlatives — "best", "top-rated", "leading", "premier" — are treated as unjustified-expectation claims when they are not backed by an objective, verifiable, and disclosed methodology. Unsupported superlatives are one of the top-cited advertising violation patterns in Georgia Composite Medical Board dispositions. The defensible construction cites a specific ranking source, date and methodology on the same page, and links to the underlying methodology.
Telehealth advertising and the Georgia licensure overlay
Georgia telehealth practice is governed by O.C.G.A. § 43-34-31 (telemedicine) and Rule 360-3-.09. A physician treating a Georgia-resident patient by telehealth is practising medicine in Georgia and must hold a Georgia licence at the time of the encounter, with narrowly-drawn exceptions for consulting and emergency care.
The advertising implication is direct. Marketing that offers telehealth services to Georgia residents must be truthful about which physicians on the roster are Georgia-licensed and available to treat Georgia patients. Advertising a national telehealth service on a Georgia-facing landing page without qualifying availability by state licensure is deceptive under O.C.G.A. § 43-34-8. The defensible construction lists the Georgia-licensed physicians on the roster and states the licensure basis on the same page.
Digital advertising — SEO, ads, social, review platforms
Every Georgia rule applies identically to digital surfaces. Four digital-specific patterns deserve separate calibration.
SEO and AI Overview content
Ranked or generative-AI-cited content touching Georgia patients is advertising for Board purposes. Landing pages, condition explainers, and long-form guides need the same substantiation, currency and typicality controls as paid media. Author every long-form healthcare page with a byline, a "medically reviewed by" line, a review date, and source citations. The substantiation trail is what a Georgia inspector will look for.
Paid search and paid social
Paid-search creative and paid-social copy are subject to two overlays in addition to Georgia: the ad platform's own healthcare policy, and — for pixel-based tracking — the federal HIPAA rules on disclosure of PHI to third-party trackers. The physician remains responsible for every rendered variation, not just the templates. Practices must maintain a review workflow that inspects the rendered ads with dynamic-keyword-insertion in place.
Google Business Profile and directory listings
Directory content is advertising for Georgia purposes. GBP descriptions, categories, hours and photographs — and the same on health directories, insurance directories and physician-listing sites — must satisfy the same currency and substantiation controls as any other advertising. A stale profile with a departed physician, an outdated service, or an obsolete credential is deceptive by omission.
Review platforms and responses
The practice's own review response is advertising by the practice. Two failure modes recur. First, confirming a patient's presence in a review response — a HIPAA disclosure regardless of the reviewer's own posted content. Second, publishing a rebuttal that names or characterises the specific care rendered — again a PHI disclosure. The safe response pattern is a de-identified, standard reply that thanks the reviewer, invites offline discussion, and does not confirm or deny the reviewer's patient status.
Enforcement patterns and disciplinary risk
Complaint-driven inquiries
Most Georgia Composite Medical Board advertising inquiries start with a complaint from a patient, a competitor, or a consumer-protection screening. The Board's investigative unit issues a formal request for response and initial documentary production.
Consent orders and civil penalties
Common outcomes include consent orders requiring corrective advertising, civil penalties under O.C.G.A. § 43-34-8, mandatory continuing-education, probationary supervision, or — for serious or repeated conduct — suspension or revocation of the licence.
Public discipline record
Discipline is published on the Georgia Composite Medical Board licence-verification portal. A finding of deceptive advertising is a permanent, searchable record against the physician's licence.
GFBPA parallel action
The Georgia Attorney General can bring a parallel action under the Fair Business Practices Act at O.C.G.A. § 10-1-390 et seq. with civil penalties, restitution, and injunctive relief separate from any Board disposition.
Federal overlay — HIPAA, FTC, TCPA, ADA
Georgia advertising rules do not preempt or relax federal requirements. Every campaign has to clear all of them.
- HIPAA Privacy Rule (45 CFR 164). Any advertising that uses PHI requires prior written authorisation. Any third-party tracker on a page that combines an IP address with a condition URL is a disclosure of PHI under the 2022/2024 OCR bulletins.
- FTC Act Section 5. Deceptive or unfair advertising is a federal violation independent of Georgia rules. FTC endorsement guides at 16 CFR 255 govern testimonials nationwide.
- TCPA (47 USC 227). Marketing texts and pre-recorded calls require prior express written consent. Statutory damages are USD 500 to USD 1,500 per unlawful message and aggregate in class actions.
- ADA Title III. Practice websites are places of public accommodation under most federal appellate readings. WCAG 2.2 AA is the operative reference standard, and Georgia inspectors have increasingly cited accessibility failures alongside deceptive-practice complaints.
Georgia advertising rules — common questions
Does the Georgia Composite Medical Board preapprove physician advertising?
No. The Board does not preapprove advertising. It enforces O.C.G.A. § 43-34 and Board Rule 360-3 after publication. The correct framing is "reviewed against Georgia medical-board rules".
What is Georgia's deceptive-advertising standard?
Under O.C.G.A. § 43-34-8 and Rule 360-3, advertising is deceptive when it contains a material misrepresentation, omits a material fact, or creates an unjustified expectation of results. The Board reads the standard against the impression created for a reasonable patient.
Are patient testimonials allowed in Georgia?
Yes, if they are identified, current and truthful, with consideration disclosed and atypical outcomes flagged. Patient-identifying testimonials require prior HIPAA authorisation.
Are "best" or "leading" claims allowed?
Only with objective, verifiable substantiation cited on the same page. Unsupported superlatives are one of the top-cited patterns in Georgia Board dispositions.
Which credentials can we advertise?
Board certification is safe when the certifying body is ABMS- or AOA-BOS-member. Fellowship claims must reflect a completed accredited fellowship. "Specialising in" phrases must not imply a certification the physician does not hold.
Does Georgia have specific telehealth advertising rules?
Yes. Under O.C.G.A. § 43-34-31 and Rule 360-3-.09, a physician treating Georgia patients by telehealth must hold a Georgia licence at the time of the encounter. Advertising Georgia-facing telehealth requires Georgia-licensed physicians on the roster and a truthful representation of availability by state.
Is this guide legal advice?
No. This is marketing best practice reviewed for alignment with Georgia Composite Medical Board advertising rules. Consult a healthcare-marketing attorney and the Board before publishing.
Scope a Georgia-safe advertising review
Book a 30-minute call with a member of the ICG Global Leadership Team, email the US practice lead, or WhatsApp us in your time zone. Retainers are custom-scoped per engagement — from USD ~$250/month equivalent (approx Rs 20,000).
Continue the state-board stack
Healthcare brands ICG
has worked with.
A representative slice of the 150+ healthcare brands ICG has delivered for across India. Full client list available under NDA during a Brand and Growth Diagnostic.